Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Orchestra BioMed Holdings Q3 2026 Results: Net Loss of $18.8M, Loss Narrows

Orchestra BioMed reported a significant decrease in total revenue to $0.29 million for the nine months ended September 30, 2026, compared to $2.57 million in the prior year, primarily due to the absence of partnership revenue. The company's total stockholders' equity declined from $53.6 million to $7.8 million as the accumulated deficit reached $425.8 million.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue0.10.9
Net income-18.8-20.8
EPS (diluted, $ a share)$-0.30$-0.40

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year-89.4%
Source

10-Q filed with the SEC, NASDAQ: OBIO. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Orchestra BioMed Holdings, Inc.: key numbers

Share price
$7.12Close, Nov 16
Market cap
$560M
Shares outstanding
78.7MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Orchestra BioMed Holdings, Inc.

All →
4:28 PM ET Form 4
Insider Buying

Orchestra BioMed Holdings 10% Owner Rtw Investments LP Buys $6M of Stock

Rtw Investments LP, 10% Owner, bought 1,200,000 shares of Orchestra BioMed Holdings, Inc. at $5.00 a share, worth $6M in total on Nov 9, 2026. Shares held after the trade: 10,756,063 (+12.6%).

Value
$6M
Shares
1,200,000
Price
$5.00
Role
10% Owner
Holding change
+12.6%
Trade date
Nov 9, 2026
4:32 PM ET Form 4
Insider Buying

Orchestra BioMed Holdings Insider Eric S. Fain Buys $100K of Stock

Eric S. Fain bought 20,000 shares of Orchestra BioMed Holdings, Inc. at $5.00 a share, worth $100K in total on Nov 9, 2026. Shares held after the trade: 119,630 (+20.1%).

Value
$100K
Shares
20,000
Price
$5.00
Holding change
+20.1%
Trade date
Nov 9, 2026
4:32 PM ET Form 4
Insider Buying

Orchestra BioMed Holdings Insider David Pacitti Buys $100K of Stock

David Pacitti bought 20,000 shares of Orchestra BioMed Holdings, Inc. at $5.00 a share, worth $100K in total on Nov 9, 2026. Shares held after the trade: 74,750 (+36.5%).

Value
$100K
Shares
20,000
Price
$5.00
Holding change
+36.5%
Trade date
Nov 9, 2026
4:32 PM ET Form 4
Insider Buying

Orchestra BioMed Holdings Insider David P. Hochman Buys $25K of Stock

David P. Hochman bought 5,000 shares of Orchestra BioMed Holdings, Inc. at $5.00 a share, worth $25K in total on Nov 9, 2026. Shares held after the trade: 437,916 (+1.2%).

Value
$25K
Shares
5,000
Price
$5.00
Holding change
+1.2%
Trade date
Nov 9, 2026
4:16 PM ET 8-K
Capital Raise

Orchestra BioMed Holdings Capital Raise of $86.3M

Orchestra BioMed closed an underwritten public offering of 17,250,000 shares of common stock, which included the full exercise of the underwriters' over-allotment option. The offering was priced at $5.00 per share, generating gross proceeds of approximately $86.3 million. The company intends to use the funds to support its AVIM Therapy and Virtue SAB clinical programs, including the BACKBEAT global pivotal trial.

Value
$86.3M
Counterparty
Piper Sandler & Co.
5:15 PM ET Form 4
Insider Selling

Orchestra BioMed Holdings Insider Darren Sherman Sells $86.1K of Stock

Darren Sherman sold 15,000 shares of Orchestra BioMed Holdings, Inc. at $5.74 a share, worth $86.1K in total on Nov 2, 2026. Shares held after the trade: 1,104,402 (-1.3%).

Value
$86.1K
Shares
15,000
Price
$5.74
Holding change
-1.3%
Trade date
Nov 2, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.